jueves, 16 de julio de 2020

NIH: National Institute of Allergy and Infectious Diseases | Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases

NIH: National Institute of Allergy and Infectious Diseases | Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases

NIH/NIAID Template Banner



July 15, 2020 NIAID Funding News

Feature Articles 

New Emergency Opportunity Funds PPE for COVID-19 Clinical Research

Our new funding opportunity announcement is designed to support purchase of personal protective equipment (PPE) for NIAID-funded clinical trials and clinical studies on COVID-19.

Opportunities and Resources

Through a new notice of special interest (NOSI), NIAID will support current awardees’ infrastructure as required for a robust SARS-CoV-2/COVID-19 research response.
Explore NIAID's priority topics for the recently reissued parent funding opportunity announcements for Small Business Innovation Research and Small Business Technology Transfer grants.
Be aware of a few time-sensitive steps you will need to take in order to apply for the funding opportunity announcement Expanding Extramural Research Opportunities at the NIH Clinical Center.
Our ongoing initiative fills a critical scientific need for scarce in vitro and in vivo reagents, enabling rigorous and innovative clinically-relevant research with nonhuman primate animal models.
NIAID will continue to support innovative methods and tool development for data analysis, data collection and management, data sharing, data reuse, and sustainability.

In The News

When applying to a program announcement with special receipt, referral, and/or review considerations (PARs) or a program announcement with set-aside funds (PASs), be mindful of any listed nonresponsive criteria.
Awardee institutions, make sure you understand NIH’s prior approval and notification requirements in support of fostering a harassment-free work environment.
NIH invites comments and suggestions on methods to improve scientific rigor in biomedical research involving animal models.
Those who have the signing official role in the eRA Commons can now view overall impact scores as well as current and previously issued summary statements.

Advice Corner

When you’re ready to publicize your scientific discoveries, NIAID can help spread the word. After you submit a research paper to a journal, share a copy with our News and Science Writing Branch.

Reader Questions

New Funding Opportunities

  • NOT-AI-20-061, Notice of Special Interest—Notice of Availability of Funds for Administrative Supplements for Pediatric Radiation/Nuclear Animal Models, MCM, Biodosimetry Development
  • PA-20-260, PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44], Clinical Trial Not Allowed)
  • PA-20-265, PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42], Clinical Trial Not Allowed)
  • PAR-20-256, Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10, Clinical Trial Not Allowed)
  • PAR-20-129, SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
  • NOT-AI-20-059, Notice of Special Interest (NOSI)—Emergency Competitive Revisions for Select Research Activities Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
  • PA-20-251, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
Find other announcements at NIAID Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.

No hay comentarios: